Disseminated tumour cells as a prognostic biomarker in colorectal cancer

Autor: Heidi Rasmussen, Elin Borgen, Jacobsen Hj, Rosales R, Kjersti Flatmark, Jahn M. Nesland, Kjetil Boye, Øystein Fodstad, Johannessen Ho, Ida Rashida Khan Bukholm, B. Sandstad, Hårklau L

Publikováno v: British Journal of Cancer

BACKGROUND: The study was performed to determine detection rate and prognostic relevance of disseminated tumour cells (DTC) in patients receiving curatively intended surgery for colorectal cancer (CRC). METHODS: The study population consisted of 235

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e3a9c77799f6de79a9cb3ccb9e8568e
http://europepmc.org/articles/PMC3101945

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Western European Variation in the Organization of Esophageal Cancer Surgical Care.

Autor: Visser MR; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.; Scientific Bureau, Dutch Institute for Clinical Auditing, Leiden, the Netherlands., Voeten DM; Department of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, the Netherlands., Gisbertz SS; Department of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, the Netherlands., Ruurda JP; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands., Achiam MP; Department of Surgery and Transplantation, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark., Nilsson M; Department of Upper Gastrointestinal Diseases, Karolinska University Hospital and Department of Clinical Science Technology and Interventions, Stockholm, Sweden., Markar SR; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK., Pera M; Section of Gastrointestinal Surgery, Hospital del Mar, Department of Surgery, Universitat Autònoma de Barcelona, Hospital del Mar Medical Research Institute (IMIM), Barcelona, Spain., Rosati R; Department of Gastrointestinal Surgery, IRCCS San Raffaele Scientific Institute, Milan, Italy., Piessen G; Department of Digestive and Oncological Surgery, Claude Huriez University Hospital, Lille, France., Nafteux P; Department of Thoracic Surgery, University Hospitals Leuven, Leuven, Belgium., Gutschow CA; Department of Surgery and Transplantation, University Hospital Zurich, Zurich, Switzerland., Grimminger PP; Department of General, Visceral and Transplant Surgery, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Räsänen JV; Department of General Thoracic and Esophageal Surgery, Heart and Lung Centre, Helsinki University Hospital, Helsinki, Finland., Reynolds JV; Trinity St. James's Cancer Institute, St. James's Hospital, Dublin, Ireland., Johannessen HO; Department of Gastroenterological Surgery, Oslo University Hospital, Oslo, Norway., Vieira P; Digestive Cancer Unit, Champalimaud Clinical Centre - Champalimaud Foundation, Lisbon, Portugal., Weitzendorfer M; Department of Surgery, Paracelsus Medical University Salzburg, Salzburg, Austria., Kechagias A; Department of Surgery, Athens Metropolitan Hospital, Athens, Greece., van Berge Henegouwen MI; Department of Surgery, Amsterdam UMC location University of Amsterdam, Amsterdam, the Netherlands.; Cancer Treatment and Quality of Life, Cancer Center Amsterdam, Amsterdam, the Netherlands., van Hillegersberg R; Department of Surgery, University Medical Center Utrecht, Utrecht, the Netherlands.

Publikováno v: Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus [Dis Esophagus] 2024 Aug 29; Vol. 37 (9).

Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial.

Autor: Nilsson K; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm., Klevebro F; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm., Sunde B; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm., Rouvelas I; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm., Lindblad M; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm., Szabo E; Department of Surgery, Faculty of Medicine and Health, Örebro University Hospital, Örebro., Halldestam I; University Hospital of Linköping, Linköping., Smedh U; Department of Surgery, Sahlgrenska University Hospital, Gothenburg., Wallner B; Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå., Johansson J; Department of Surgery, Skåne University Hospital, Lund, Sweden., Johnsen G; Department of Gastrointestinal Surgery, St. Olav's Hospital, Trondheim University Hospital, Trondheim., Aahlin EK; Department of GI and HPB Surgery, University Hospital of Northern Norway, Tromsø., Johannessen HO; Department of Gastrointestinal Surgery, Oslo University Hospital, Oslo, Norway., Alexandersson von Döbeln G; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm; Medical Unit of Head, Neck, Lung and Skin Cancer, Karolinska University Hospital, Stockholm, Sweden., Hjortland GO; Department of Oncology, Oslo University Hospital, Oslo, Norway., Wang N; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm., Shang Y; Department of Medicine Huddinge, Karolinska Institutet, Stockholm., Borg D; Department of Oncology, Skåne University Hospital, Lund, Sweden., Quaas A; Institute of Pathology, University of Cologne, Cologne., Bartella I; Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany., Bruns C; Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany., Schröder W; Department of General, Visceral, Cancer and Transplantation Surgery, University Hospital of Cologne, Cologne, Germany., Nilsson M; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm; Division of Surgery and Oncology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm. Electronic address: magnus.nilsson@ki.se.

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2023 Nov; Vol. 34 (11), pp. 1015-1024. Date of Electronic Publication: 2023 Aug 30.